One protein, two personalities: Study identifies new mechanism of cancer spread

December 11, 2013
One protein, two personalities: Study identifies new mechanism of cancer spread
Mice with tumor cells expressing Exo70M (left) had more cancerous nodules in their lungs than mice with cells expressing Exo70E.

Cancer involves a breakdown of normal cell behavior. Cell reproduction and movement go haywire, causing tumors to grow and spread through the body.

A new finding by University of Pennsylvania scientists has identified key steps that trigger this disintegration of cellular regulation. Their discovery—that a protein called Exo70 has a split personality, with one form keeping under tight control and another contributing to the ability of tumors to invade distant parts of the body—points to new possibilities for diagnosing cancer spread.

The research, published in the journal Developmental Cell, was conducted by a team comprised of researchers from the School of Arts and Sciences' Department of Biology; the Perelman School of Medicine's pathobiology and laboratory medicine, medicine and genetics departments, and China's Hangzhou Normal University School of Medicine.

"It turns out that one form of Exo70 is important in maintaining 'law and order' in cells, keeping them structured and organized in tissues" said senior author Wei Guo, an associate professor of biology, "while the other form promotes cell movement."

This was not the first time that Guo's group had focused on Exo70, which plays a role in the process known as exocytosis, by which cells transport proteins and other molecules such as hormones and neurotransmitters to the membrane and release them. In previous work, combining biochemistry, ultrastructure cell imaging and mathematical modeling, they showed that Exo70 and a host of other proteins, collectively known as the exocyst, are involved in cell migration, and that Exo70 itself is critical for cell membranes to initiate movement by bending the cell's plasma membrane.

But it turns out that the Exo70 they were studying was only one of five forms present in cells. In the current work, they found that one of these forms was associated with , which line the body's organs and cavities. They called this form Exo70E. The form they had studied in previous work was associated with , or cells that are highly motile. They called this form Exo70M.

The fact that these forms associated with epithelial and mesenchymal cells, respectively, caused the researchers to think about a process called the epithelial-mesenchymal transition, or EMT. In it, epithelial cells, which are normally tightly packed together and structured, acquire the ability to migrate. EMT is a normal part of cell biology that occurs in processes such as neural tube formation and wound healing, but also occurs at the beginning of cancer metastasis.

To see what role Exo70 might be playing in EMT, the researchers studied a laboratory cell line in which they could induce EMT. As the transition occurred, they observed that levels of Exo70E declined while Exo70M rose. They found that a protein called epithelial splicing regulatory protein 1, or ESRP1, appeared to play a role in switching between forms, promoting the Exo70E form and preventing EMT from occurring. ERSP1 itself has been shown by Perelman School of Medicine researchers, including Associate Professor of Medicine Russ Carstens, to be a major regulator in EMT.

Experimenting further to investigate how the two forms of Exo70 affected cell behavior, the team found that adding Exo70E to mesenchymal cells caused them to look more like epithelial cells, retaining structure and inhibiting movement. When they inhibited all forms of Exo70 in a line of , the lost their ability to migrate, a necessary part of tumor invasion. Adding back Exo70M, however, allowed these cells to regain their ability to migrate and invade, while Exo70E did not.

These results were upheld in experiments in mice. The researchers inoculated the mice with breast cancer cells that had been genetically engineered to express either Exo70E or Exo70M. Normally, the would spread all around the body and indeed, this is what the researchers saw in the mice exposed to the cells with the Exo70M form. But there was no evidence of such metastasis in mice given cells expressing only Exo70E.

"In this case, Exo70E was behaving almost like a tumor suppressor," Guo said.

Finally, to see if their findings would be clinically relevant in humans, the researchers looked for the different forms of Exo70 in tissue from human patients.

"We found that patients who had a high E-to-M form ratio had cancers that were less likely to have spread," Guo said. "Patients who had cancers that spread to the lymph nodes had more of the M form."

Such a finding offers a potential biomarker for clinicians to judge the progression of cancers, or the likelihood of a particular case of cancer to spread.

Explore further: Researchers describe a new function of two molecules involved in metastasis

More information:

Related Stories

Researchers describe a new function of two molecules involved in metastasis

November 14, 2013
Researchers from IMIM (Hospital del Mar Medical Research Institute) lead by Dr. Sandra Peiró have described a new function for two key molecules involved in tumor progression. Transcription factor SNAIL1 and enzyme LOXL2 ...

Tracking the cell transitions that cause cancer

March 6, 2013
Researchers think that for cancer to develop, damaged cells have to undergo certain transitions that cause them to spread, or metastasize. Junior Tristan Bepler, a biology and computer science major, is testing this hypothesis, ...

Transition in cell type parallels treatment response, disease progression in breast cancer

January 31, 2013
A process that normally occurs in developing embryos – the changing of one basic cell type into another – has also been suspected of playing a role in cancer metastasis. Now a study from Massachusetts General Hospital ...

Why tumor cells go on dangerous tours

November 4, 2013
Tumors become highly malignant when they acquire the ability to colonize other tissues and form metastases. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have identified a factor that promotes metastasis ...

Recommended for you

Could a green sponge hold cancer-fighting secrets?

July 27, 2017
A small green sponge discovered in dark, icy waters of the Pacific off Alaska could be the first effective weapon against pancreatic cancer, researchers said on Wednesday.

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.